|
个人信息Personal Information
实验师
性别：女
在职信息：在职
所在单位：药学院
入职时间：1991-07-01
扫描关注
Combination therapy with miR34a and doxorubicin synergistically inhibit DOX-resistance breast cancer progression via downregulation of Snail through suppressing Notch/NF-κB and Ras/Raf/MEK/ERK signaling pathway
点击次数：
所属单位：药学院
发表刊物：ACTA PHARMACEUTICA SINICA B
第一作者：郭秀丽
论文类型：应用研究
论文编号：5E71135CE5AF4FC1989F36CB7ED3CEF9
卷号：11
期号：9
页面范围：2819
是否译文：否
发表时间：2021-09-01
上一条：NIR-triggerable ROS-responsive cluster-bomb-like nanoplatform for enhanced tumor penetration, phototherapy efficiency and antitumor immunity
下一条：Anti-thrombotic activity of phenolic acids obtained from Salvia miltiorrhiza f. alba in TNF-alpha-stimulated endothelial cells via the NF-kappa B/JNK/p38 MAPK signaling pathway